Overview

Comparison of Efficacy Different Treatment Regimens in Pulmonary Hypertension Secondary to Lung Disease and or Hypoxia

Status:
Unknown status

Trial end date:
2013-07-01

Target enrollment:

Participant gender:

Summary

This is an open label, randomized, interventional study indented to find the efficacy of different treatment regimens in treatment of pulmonary hypertension secondary to lung disease and/or hypoxia.This is to find out when to start combination therapy (sildenafil plus bosentan) in treatment of pulmonary hypertension secondary to lung disease and/or hypoxia.

Phase:

Phase 4

Details

Lead Sponsor:

All India Institute of Medical Sciences, New Delhi

Treatments:

Bosentan
Sildenafil Citrate